EQUITY RESEARCH MEMO

Allele Diagnostics

Generated 5/10/2026

Executive Summary

Conviction (model self-assessment)55/100

Allele Diagnostics is a specialized genetic testing laboratory based in San Diego, offering microarray, karyotyping, and FISH testing services for prenatal, pediatric, and neonatal diagnostics. The company differentiates itself through fast turnaround times, accurate reporting, and integrated genetic counseling services, positioning it as a reliable partner for clinicians. Founded in 2015, the company operates in the competitive diagnostics market but lacks disclosed funding or revenue figures, suggesting it may be a smaller, privately held entity. Its focus on high-quality testing and client support provides a niche in a market driven by demand for rapid and precise genetic insights, though scalability and market share remain uncertain without transparent financial or operational data.

Upcoming Catalysts (preview)

  • Q4 2026Expansion into Non-Invasive Prenatal Testing (NIPT) Services40% success
  • Q2 2027Partnership with Regional Hospital Systems35% success
  • Q3 2026Introduction of New Genetic Screening Panels45% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)